Stifel downgraded Staar Surgical (STAA) to Hold from Buy with a price target of $28, up from $20, following the proposed acquisition by Alcon (ALC). The acquisition makes sense strategically and the valuation paid appears attractive for Alcon, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on STAA: